Klinik fur Innere Medizin Hamatologie and Onkologie

Berlin 10967

0 studies enrolling now · 2 studies all time

What they study most

Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), DLBCL, FL, Follicular Lymphoma, High-grade B-cell Lymphoma (HGBCL), Indolent B-cell Non-Hodgkin Lymphoma (iNHL), MCL, Marginal Zone Lymphoma, Marginal Zone Lymphoma (MZL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), Small Lymphocytic Lymphoma (SLL)

Studies at this site

• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling